Special Issues

Special Issue Title: Minimizing Morbidity in Gynecological Oncology

· Print Special Issue Flyer

· Deadline for manuscript submissions: 31 January 2022

Special Issue Editor

Guest Editor

Dr. Ahmed Abu-Zaid

Department of Obstetrics and Gynecology, Alfaisal University, Riyadh, Saudi Arabia

Website E-Mail

Interests: Oncology; Gynecology; Obstetrics; Cancer Diagnostics; Tumor Biology; Cancer Metastasis; Tumor Markers

Dr. Osama Alomar

Department of Obstetrics and Gynecology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

Website E-Mail

Interests: Gynecological Oncology; Minimally Invasive Surgery; Hyperthermic Intraperitoneal Chemotherapy; Cancer Diagnostics

Special Issue Information

Dear Colleagues,

Accumulating body of evidence suggest that the incidence rate of gynecological tumors is rapidly increasing over time. Gynecological oncology comprises a heterogeneous cluster of malignancies, such as the tumors of the endometrium, ovary, cervix, and vulva. The primary treatment of the vast majority of gynecological cancers is surgery. Unfortunately, the procedures of gynecological oncology are often complex and associated with high morbidity rates reaching up to as high as 90%. Such morbidities are undesirable and represent a paramount matter for both the gynecological oncology physicians and patients. Moreover, these morbidities greatly have a negative impact on the utilization of healthcare resources. Therefore, it is critically important to identify those patients who may likely benefit from particular perioperative interventions to minimize such gynecological oncology related morbidities. 

These gynecological oncology related morbidities can take place before, during, or after the surgical intervention. Sometimes, prior to undergoing the frontline surgical intervention, some gynecological oncology patients may undergo select preoperative procedures, such as hysteroscopy, colposcopy, hysterosalpingogram, just to name a few. Such procedures themselves can often associate with additional morbidities before the surgical intervention, such as pain, infections, and iatrogenic injuries. Furthermore, some select gynecological procedures, such as aggressive cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), often associate with heightened hazards of morbidities, and such interventions are often of a special concern to the operating surgeons and patients alike.

In this special issue, we look forward to exciting research investigations geared toward minimizing morbidity in gynecological oncology. Specifically, areas of research should focus on novel technical advances and pharmacological agents to reduce a wide array of morbidities in gynecological oncology, such as intraoperative blood loss, postoperative pain control, infection, intragenic injures to important structures (for example ureter), and cosmetic outcomes. Notably, the scope of this special issue is broad and includes surgeries (such as: hysterectomy, cystectomy, CRS, HIPEC, single-port laparoscopy, etcetera) as well as preoperative procedures (such as: hysteroscopy, colposcopy, hysterosalpingogram, etcetera). Additionally, this issue will include studies about minimally invasive surgery and how it can decrease morbidity of gynecological oncology. Lastly, we welcome any contributions that may directly or indirectly minimize morbidity in gynecological oncology, inclusive of adjuvant chemotherapeutic regimens. All types of manuscripts are welcome, including full-length articles, short communications, narrative reviews, systematic reviews and meta-analyses, case reports, and special contributions.

Dr. Ahmed Abu-Zaid and Dr. Osama Alomar

Guest Editors


Manuscript Submission Information

Manuscripts should be submitted online at https://ejgo.imrpress.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. European Journal of Gynaecological Oncology is an international peer-reviewed open access quarterly journal published by IMR Press.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is $1250. Submitted papers should be well formatted and use good English.


Gynecological Cancer; Surgery; Hysterectomy; Cystectomy; Single-Port Laparoscopy; Infection; Blood Loss; Pain; Iatrogenic Injury; Morbidity; Complication

Share This Special Issue


Please wait a minute...
For Selected: Toggle Thumbnails

Current Issue

  • Volume 42, Issue 5